Why this resource exists
Many conversations about experimental treatments blend individual reports, early hypotheses, and emerging studies. Rookline exists to separate those threads: we surface what is well-supported, what remains preliminary, and where safety concerns or gaps in data require caution. If you arrived from a discussion of treatments, consider returning to our central overview of the site to explore evidence-first summaries and linked pages.
What we cover
We publish clear, plainspoken syntheses about claims and evidence. Coverage is organized into topical sections (evidence summaries, safety and risk reviews, and practical FAQs) and is kept intentionally narrow so each page focuses on a specific question or claim rather than broad advocacy. For context on services that are often discussed alongside experimental treatments, readers sometimes consult clinic directories such as ibogainesoccer's directory or regional treatment listings like ibogainetreatmentsmexico's clinic pages, but Rookline does not operate or endorse clinical providers.
How our editorial approach works
We treat evidence and anecdotes differently, and we explain that distinction on every page.
- Independence — we are not a clinic or treatment provider.
- Evidence before claims — we privilege peer-reviewed studies and registries where available.
- Plain language — complex topics are summarized transparently for non-specialist readers.
- Risk clarity — we highlight safety concerns and gaps in knowledge.
Rookline helps readers weigh early reports against established evidence, prioritizing safety and honesty about uncertainty.
Sourcing and vetting
We compile material from primary studies, trial registries, and recognized reference sources. Where we characterize clinical evidence, we cross-check summaries against registry entries (such as clinical trial records) and major reference works. For example, we link to consensus or background material such as the general clinical research overview on Wikipedia's Clinical trial for procedural context, and to institutional guidance where applicable like the NIH's research resources at nih.gov when summarizing study types and evidence strength.
We do not accept payments from clinics or product vendors; any funding sources that materially affect content are disclosed inline on affected pages.
Who this is for
Rookline is intended for people affected by cluster headache, their families, and curious clinicians or researchers seeking a careful, independent synthesis. We aim to help readers move from anecdote to evidence, and to understand risks and uncertainties before considering treatment options. Readers looking for service providers sometimes follow contextual links to directories and regional treatment lists like ibogainerelapse resources, but Rookline does not make or endorse referrals.
Independent by design
Rookline is an independent information resource, not a clinic, medical provider, or licensed treatment center. Its content is not medical or legal advice. If you are considering any intervention, consult a qualified health professional.